Timothy Regnault

Maternal, Fetal & Newborn Health Dr. Timothy Regnault
Scientist
Photo

Affiliations

Scientist, Division of Maternal, Fetal & Newborn Health, Children’s Health Research Institute
Assistant Professor, Departments of Obstetrics and Gynaecology and Physiology and Pharmacology,
Schulich School of Medicine, Western University

How my research helps children

Our research aims to understand how babies that do not grow normally while still inside the womb change their metabolism, the way the body uses energy to live and grow, to adapt to not receiving enough nutrients. These babies have slowed down their metabolism to survive inside the womb. After they are born, they are exposed to abundant nutrients and are encouraged to catch up in growth to become similar in size and weight as children that had a normal birth weight. However, as a consequence of their slower metabolism, they can not handle these nutrients well and develop diseases such as obesity, insulin resistance (the way the body uses glucose), increased blood pressure and heart disease. Our work aims to understand and develop ways to correct these changes in metabolism inside the womb, when the food supply is poor. Further, our work helps those children that are born small to grow correctly as adults, limiting the risk of these diseases in later life


Research

Current Research Activities

Our research activities are focused around the in utero origins of adult insulin resistance and vascular dysfunction. Through the use of cell based and animal model systems we investigate, primarily hypoxia/oxidative/infection stress effects upon placental, and fetal liver, kidney, heart and muscle function. These studies aim to address what reprogramming events these stressors cause in utero and what are the implications of these changes for adult disease. More importantly however is understanding the degree of plasticity of these changes, are they locked or are there windows of opportunity for us to intervene and rescue some of these unfavorable in utero-induced changes.

Research Team

Jeni Thompson (Ph.D. candidate) and David Kao (M.Sc.candidate) are the two graduate trainees in the laboratory. Jeni works on the in utero development of vascular dysfunction as it relates to hypertension in later life, while David’s work deals with investigating how insults in utero impact upon muscle nutrient transport and metabolism and its ultimate effect upon insulin sensitivity.  The diseases of vascular dysfunction and insulin resistance are the two most important precursors for the development of metabolic syndrome in later life.

Together with Dr. de Vrijer (Maternal Fetal Medicine consultant) we also study modulators of preterm rupture of membranes during pregnancy, with a special interest in the effects obesity plays in this and its regulation of fetomembrane nutrient transport and utilization. With Dr. Andreana Bütter (Pediatric cardiologist), we are also undertaking studies investigating the molecular origins and possible interventions of dysfunction lungs following congenital diaphragmatic hernia in utero.

With Drs. Lee (Robarts imaging) and Staples (Biology) we continue our insulin sensitivity work in IUGR offspring, specifically addressing in utero induced alterations in muscle insulin sensitivity with PET and associated body composition changes with CT and mitochondrial function studies.

Dr. Lin Zhao is our senior research technician and together we supervise a number of Residents, Medical and undergraduate student research projects. Recently these projects have included investigations of low protein inductions of hypertension in growth retarded fetuses, effects of infection upon human fetal blood and amnion and the effect of placental insufficiency upon fetal hepatic antioxidative capacity.

Future Research Plans

We will continue to address the above studies, while at the same time embarking on some new exciting investigations. Recently Katie Belgrave has joined our group as a M.Sc. candidate and will be focusing her efforts upon adverse in utero environment modulation of fetal and adult muscle mitochondrial activity and how these changes are modulated in situations of high fat/carbohydrate diets. Additionally, we will expand our pilot studies investigating the role that hypoxia during development may have upon cardiac remodeling, diastolic dysfunction, and increased sensitivity to ischemic injury in adult life.

Awards & Grants

Awards & Grants

Funding in support of Telomerase Therapy for Intrauterine Growth Restriction (IUGR) – Awarded by Lawson Health Research Institute (LHRI)

Funding in support of In utero insults and adult insulin resistance – Awarded by Canadian Institute of Health Research (CIHR)

Funding in support of Fetal endotoxin exposure and regulation of amino acid supply – Awarded by NSERC

Funding in support of High Resolution Multisensor Respirometer – Awarded by NSERC

Funding in support of Altered programming of muscle oxidative capacity in cell and animal hypoxic models – Awarded by The University of Western Ontario

Funding in support of The impact of dietary fatty acids on inflammation during pregnancy, lactation and fetal development – Awarded by NSERC

Funding in support of A laboratory for investigating the role of fetal programming in Metabolic Syndrome – Awarded by Canada Foundation for Innovation (CFI)

Funding in support of Measuring Changes in Nuclear Receptor Binding During Fetal and Neonatal Development Using Chromatin Immunoprecipitation (ChIP) – Awarded by NSERC

Funding in support of The hypoxic induced cellular release of the amino acid osmolyte, taurine: Regulation and interaction with cellular hypoxia induced apoptosis in a fetal guinea pig model of growth restriction – Awarded by The University of Western Ontario

Funding in support of Increased skeletal muscle cationic amino acid transporter, CAT2A, mRNA concentrations occurs under hypoxia, the result of posttranscriptional cleavage of nuclear retained CAT mRNA – Awarded by Lawson Health Research Institute

Funding in support of The molecular mechanisms of hypoxic induced impaired amino acid transport in FGR – Awarded by Lawson Health Research Institute

Funding in support of An examination of how hypoxia inflencues cellular energy balance and impacts oxidative properties – Awarded by The University of Western Ontario

Funding in support of The effects of hypoxia upon fetal tissue methylation status – Awarded by The University of Western Ontario

Recent Publications

Publications

Central Stiffening in Adulthood Linked to Aberrant Aortic Remodeling Under Suboptimal Intrauterine Conditions. Thompson JA, Gros R, Richardson B, Regnault TRH. American Journal of Physiology - Heart and Circulatory Physiology. 2011 Sept; IF:4.69.

Chronic Intrauterine Hypoxia Interferes with Aortic Development in the late Gestation Ovine Fetus. Thompson JA, Richardson BS, Gagnon R, Regnault TRH. Journal of Physiology. 2011 May 3. [Epub ahead of print]

In utero origins of adult insulin resistance and vascular dysfunction. Thompson JA, Regnault TRH. Seminars in Reproductive Medicine. 2011; 29(3):211-224.

Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscle. Thorn SR, Regnault TR, Brown LD, Rozance PJ, Keng J, Roper M, Wilkening RB, Hay WW Jr, Friedman JE  Endocrinology. 2009 Jul;150(7):3021-30

Effects of early gestation GH administration on placental and fetal development in sheep
Wright CD, Orbus RJ, Regnault TR, Anthony RV. J Endocrinol. 2008 Jul;198(1):91-9.

Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep.  Rozance PJ, Limesand SW, Barry JS, Brown LD, Thorn SR, LoTurco D, Regnault TR, Friedman JE, Hay WW Jr. Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E365-70

Ontogeny of endothelial nitric oxide synthase mRNA in an ovine model of fetal and placental growth restriction.  Ziebell BT, Galan HL, Anthony RV, Regnault TR, Parker TA, Arroyo JA
Am J Obstet Gynecol. 2007 Oct;197(4):420.e1-5.

The expression of ovine placental lactogen, StAR and progesterone-associated steroidogenic enzymes in placentae of overnourished growing adolescent ewes.  Lea RG, Wooding P, Stewart I, Hannah LT, Morton S, Wallace K, Aitken RP, Milne JS, Regnault TR, Anthony RV, Wallace JM
Reproduction. 2008 Jun;135(6): 889

Heterodimeric amino acid transporters in the placenta--a workshop report.  Regnault TR, Kudo Y, Glazier J, Roos S, Lewis RM, Jansson T  Placenta. 2007 Apr;28 Suppl A:S103-6.

Altered placental and fetal expression of IGFs and IGF-binding proteins associated with intrauterine growth restriction in fetal sheep during early and mid-pregnancy.  de Vrijer B, Davidsen ML, Wilkening RB, Anthony RV, Regnault TR   Pediatr Res. 2006 Nov;60(5):507-12

Development and mechanisms of fetal hypoxia in severe fetal growth restriction.  Regnault TR, de Vrijer B, Galan HL, Wilkening RB, Battaglia FC, Meschia G  Placenta. 2007 Jul;28(7):714-23

Developmental changes in ovine myocardial glucose transporters and insulin signaling following hyperthermia-induced intrauterine fetal growth restriction.  Barry JS, Davidsen ML, Limesand SW, Galan HL, Friedman JE, Regnault TR, Hay WW Jr  Exp Biol Med (Maywood). 2006 May;231(5):566-75.

In vivo techniques for studying fetoplacental nutrient uptake, metabolism, and transport
Regnault TR, Hay WW Jr.  Methods Mol Med. 2006;122:207-24.

Additional publications

Contact

Phone: 519-661-2111 x 83528
Fax: 519-661-3827
Email: tim [dot] regnault [at] uwo [dot] ca
Website: http://www.uwo.ca/physpharm/faculty/regnault_timothy.html

(Please note: CHRI is not responsible for the content of any external sites - links will open in new window)